Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.

Conditions:   Prostate Cancer;   Benign Prostatic Hypertrophy;   Bladder Stones;   Kidney Stones Intervention:   Diagnostic Test: NV-VPAC1 PCa Urine Diagnostic Test Sponsors:   Intermountain Health Care, Inc.;   NuView Diagnostics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials